CancerFax
Share
CancerFax is a leader in advanced cancer treatment management. We work with top cancer hospitals in the world to facilitate treatment with the latest therapies like Gene therapy, CAR T-cell therapy, TCR T Cell therapy, Cancer Vaccine, TIL therapy, T-cell therapy and proton therapy.
29/03/2026
🚀 Exciting News in Cancer Treatment! 🚀
The FDA has now approved Hernexeos (zongertinib) as the first treatment option for adults with HER2-Mutant non-small cell lung cancer. This breakthrough means that 76% of patients saw their tumors shrink, offering new hope and improved outcomes for many.
Stay informed with CancerFax Insights, your trusted source for the latest in cancer care and oncology.
Read more about this significant advancement here: https://cancerfax.beehiiv.com/p/fda-expands-approval-of-hernexeos-for-first-line-her2-mutant-lung-cancer-76-of-patients-saw-tumors-s
Click here to claim your Sponsored Listing.
